Anticancer Drugs May Hold Key to Parasite Treatment
By Sharon Kingman
Tuesday, March 19, 2013
LONDON The genome of the tapeworm has been sequenced, providing researchers with a panoply of genes that may provide new targets for treatment of those parasites. Scientists hope that, by identifying tapeworm genes that are similar to human genes, it may be possible to select candidate drugs that are already approved for use against other conditions, such as cancer.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.